Helsinn Investment Fund Invests €1 Million in Gain Therapeutics

19 February 2019

Alla ricerca di talenti

12 February 2019

Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care

31 January 2019

Wound Care: new clinical data show Nexodyn® AOS To reduce reinfections and healing time in diabetic foot ulcers

31 January 2019

Gabriel Haering at the Career Chat c/o ETH Zurich

17 January 2019

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

21 December 2018

RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®

20 December 2018

Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US

12 December 2018

Wound care: Nexodyn® AOS comes to fruition in Slovakia

12 December 2018

La farmaceutica ticinese a Madrid per la CPhI 2018

28 November 2018